Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03328429
Other study ID # 2017/220
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2017
Est. completion date May 1, 2018

Study information

Verified date June 2018
Source Kanuni Sultan Suleyman Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare intraoperative and postoperative outcomes of Bartholin marsupialisation versus excision


Description:

Bartholin cysts and abscess are commonly seen. Different surgical procedures are done for therapy. Our aim is to compare intraoperative results and postoperative healing of patients undergoing marsupialisation versus excision.


Recruitment information / eligibility

Status Completed
Enrollment 154
Est. completion date May 1, 2018
Est. primary completion date December 15, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Age 18-40, Bartholin cyst/abscess

Exclusion Criteria:

- patients with systemical diseases, patients with recurrent Bartholin abscess

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Excision
Bartholin gland will be excised
Marsupialization
Bartholin gland will be marsupialised

Locations

Country Name City State
Turkey Kanuni SSTRH Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Ozdegirmenci O, Kayikcioglu F, Haberal A. Prospective Randomized Study of Marsupialization versus Silver Nitrate Application in the Management of Bartholin Gland Cysts and Abscesses. J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):149-52. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative Patients will be followed up for three months. 3 months after the surgery, all patients will be asked to complete the Female Sexual Function Index (FSFI) questionnaire alone in a hospital room. The FSFI includes a total of 19-item validated questionnaire which was used for the evaluation of sexual desire, arousal, lubrication, orgasm, satisfaction, and pain during sexual intercourse. Scores range from 2 to 36, higher scores indicate better sexual function. Sexual dysfunction is described as having a total FSFI score of 26.55 or less. 3 months
Secondary operation time operation time during the procedure will be recorded. during procedure